Klaus Munkholm

Klaus Munkholm

Clinical Associate Professor


Publication year:
All
1 - 6 out of 6Page size: 10
  1. 2024
  2. Published

    A composite immune and vascular stress marker in patients newly diagnosed with bipolar disorder and their unaffected first-degree relatives

    Coello, K., Holstad Pedersen, H., Munkholm, Klaus, Lie Kjærstad, H., Stanislaus, S., Ostrowski, Sisse Rye, Faurholt-Jepsen, Maria , Miskowiak, Kamilla, Frikke-Schmidt, Ruth, Vinberg, Maj, Ekstrøm, Claus Thorn, Forman, Julie Lyng & Kessing, Lars Vedel, 2024, In: Brain, Behavior, and Immunity. 118, p. 449-458 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. E-pub ahead of print

    Early specialised treatment for bipolar disorder: Long-term follow-up from the early intervention in affective disorders (EIA) randomised controlled trial

    Munkholm, Klaus & Kessing, Lars Vedel, 2024, (E-pub ahead of print) In: Acta Psychiatrica Scandinavica.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Inflammatory and oxidative stress biomarkers in children and adolescents with bipolar disorder – A systematic review and meta-analysis

    Munkholm, Klaus, Mäkinen, I. J. O., Maigaard, K., Coello, K., Pagsberg, Anne Katrine & Kessing, Lars Vedel, 2024, In: Neuroscience and Biobehavioral Reviews. 163, 9 p., 105766.

    Research output: Contribution to journal › Review › Research › peer-review

  5. 2023
  6. Published

    Ferritin as a potential disease marker in patients with bipolar disorder

    Munkholm, Klaus, Jacoby, A. S., Vinberg, Maj & Kessing, Lars Vedel, 2023, In: Journal of Affective Disorders. 332, p. 247-253 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. The risks of adverse events with venlafaxine and mirtazapine versus ‘active placebo’, placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis

    Jørgensen, C. K., Juul, Sophie, Siddiqui, F., Horowitz, M. A., Moncrieff, J., Munkholm, Klaus, Hengartner, M. P., Kirsch, I., Gluud, C. & Jakobsen, J. C., 2023, In: Systematic Reviews. 12, 10 p., 57.

    Research output: Contribution to journal › Review › Research › peer-review

  8. 2021
  9. Published

    Duloxetine versus ‘active’ placebo, placebo or no intervention for major depressive disorder; a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis

    Siddiqui, F., Barbateskovic, M., Juul, Sophie, Katakam, K. K., Munkholm, Klaus, Gluud, C. & Jakobsen, J. C., 9 Jun 2021, In: Systematic Reviews. 10, 1, 171.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 365537631